Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Circulation. Cardiovascular Interventions|June 10, 2015
Impact of arterial access site on outcomes after primary percutaneous coronary intervention: prespecified subgroup analysis from the EUROMAX trialMartial Hamon, Pierre Coste, Arnoud Van't Hof, et al.
JACC. Cardiovascular Interventions|January 25, 2015
Acute stent thrombosis after primary percutaneous coronary intervention: insights from the EUROMAX trial (European Ambulance Acute Coronary Syndrome Angiography)Peter Clemmensen, Sebastian Wiberg, Arnoud Van't Hof, et al.
European Heart Journal|December 17, 2021
Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trialsMattia Galli, Stefano Benenati, Francesco Franchi, et al.
European Heart Journal|May 19, 2026
Aspirin vs clopidogrel in chronic coronary syndromes: a meta-analysis of ethnic differencesClaudio Laudani, Giovanni Occhipinti, Francesco Costa, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 5, 2024
Update on antithrombotic therapy and body mass: a clinical consensus statement of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and the European Society of Cardiology Working Group on ThrombosisBruna Gigante, Juan Tamargo, Stefan Agewall, et al.
Open Heart|November 6, 2025
Trends and risk factors of stroke and mortality after transcatheter aortic valve implantation in the NetherlandsSimon E van Putten, Romy R M J J Hegeman, Leo Timmers, et al.
European Heart Journal|April 6, 2021
Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart DiseaseJurrien Ten Berg, Dirk Sibbing, Bianca Rocca, et al.
JACC. Cardiovascular Interventions|February 11, 2026
Genotype-Guided vs Conventional Oral P2Y12 Inhibitors in Acute Coronary Syndrome: A Combined Analysis of TAILOR-PCI and POPular GeneticsMattia Galli, Naveen L Pereira, Ryan J Lennon, et al.
European Heart Journal|January 30, 2020
Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromesRobert F Storey, Paul A Gurbel, Jurrien Ten Berg, et al.
European Heart Journal|April 22, 2015
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary interventionDániel Aradi, Ajay Kirtane, Laurent Bonello, et al.
Pageof 6